ALEC

Alector, Inc.

NasdaqHealthcareBiological Products, (No Diagnostic Substances)

Insider activity for last month from 09/20 to 10/20.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$00 buys
Total selling$00 sells
Net open-market+$0Buying minus selling
Active insiders3Distinct reporting owners

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Oct 15, 2026

Open-market transaction mix · 0 transactions in the selected period

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Sep 2026000$0$0$0
Oct 20260019$0$0$0

Distinct insiders active

Reporting-owner CIKs by month · peak Oct 2026 (3)
Sep 2026: 0 insidersOct 2026: 3 insiders
Sep 2026Oct 2026
3distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
2 insiders

ALEC transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
CompanyInsiderActivityDisclosed valueFiled (ET)
ALECAlector, Inc.
Rosenthal ArnonCEOA · grantDerivative securitySEC filing ↗$0View disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOA · grantDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOD · returnDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOA · grantDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOD · returnDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOA · grantDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOD · returnDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOA · grantDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOD · returnDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOA · grantDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOD · returnDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOA · grantDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOD · returnDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOA · grantDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOD · returnDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Rosenthal ArnonCEOA · grantSEC filing ↗$0View disclosure →
ALECAlector, Inc.
Wong-Sarad GracePAOA · grantDerivative securitySEC filing ↗$0View disclosure →
ALECAlector, Inc.
Wong-Sarad GracePAOA · grantDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Wong-Sarad GracePAOD · returnDerivative securitySEC filing ↗UnknownView disclosure →
ALECAlector, Inc.
Wong-Sarad GracePAOA · grantDerivative securitySEC filing ↗UnknownView disclosure →

Filing-only signals

Deterministic matches in the selected period

Recent filing activity
Most recent 6 transactions on this page · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy-
Largest sale-
10b5-1 detected0
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
32transactionstxns
  • A · Grants / awards · dominant19 · 59%
  • D · Issuer dispositions13 · 41%

Activity by reported role

A joint filing can contribute to multiple roles
Chief executive officer16
PAO14
CBO2
Chief financial officer2

Reported Holdings After

Separated by insider, security, and ownership type

Rosenthal ArnonEmployee Stock Option (right to buy) · Direct
978.8k0Oct 13, 2026Oct 14, 2026
978,750Oct 14, 2026
Wong-Sarad GraceEmployee Stock Option (right to buy) · Direct
83.4k0Oct 13, 2026Oct 14, 2026
83,435Oct 14, 2026
Berkley Neil LindsayEmployee Stock Option (right to buy) · Direct
190.0k190.0kOct 14, 2026Oct 14, 2026
190,000Oct 14, 2026
Wong-Sarad GraceCommon Stock · Direct
161.6k161.6kOct 14, 2026Oct 14, 2026
161,570Oct 14, 2026
Rosenthal ArnonCommon Stock · Direct
2.5M2.5MOct 14, 2026Oct 14, 2026
2,512,100Oct 14, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
1 active days
Sep 20 → Oct 20
LessMore

Alector, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at Alector, Inc.?

Rosenthal Arnon, Wong-Sarad Grace, Berkley Neil Lindsay.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

No code-S sale is available for this period.

What is the recent purchase and sale balance?

No code-P purchases or code-S sales were reported in the selected period.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.